Milestone Pharmaceuticals, Inc.
(NASDAQ : MIST)

( )
MIST PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.33%38.600.9%$1295.75m
JNJJohnson & Johnson 0.32%146.290.7%$908.06m
MRKMerck & Co., Inc. 0.95%81.000.7%$632.64m
AZNAstraZeneca Plc 1.22%56.451.2%$603.18m
ABBVAbbVie, Inc. 0.21%95.101.9%$602.87m
BMYBristol-Myers Squibb Co. 0.43%58.901.0%$568.24m
LLYEli Lilly & Co. 1.84%153.001.1%$430.99m
GSKGlaxoSmithKline Plc 1.31%40.850.2%$135.54m
NVSNovartis AG 1.81%83.620.2%$131.25m
OPKOPKO Health, Inc. 3.11%5.3112.2%$129.65m
MISTMilestone Pharmaceuticals, Inc. -0.12%8.690.0%$122.63m
RGENRepligen Corp. -0.23%150.917.1%$69.52m
NVONovo Nordisk A/S -0.03%65.300.1%$64.50m
PRNBPrincipia Biopharma, Inc. 0.13%83.600.0%$56.89m
IMRNImmuron Ltd. -0.10%10.000.0%$49.87m

Company Profile

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.